← Leaderboards
Aaron Weinberg
Case Western Reserve University
$13,644,444
Attributed
$14,396,555
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$23,934,026 · 17
By mechanism
P01$12,949,422 · 5
R01$8,560,532 · 6
R21$1,312,963 · 3
R56$958,109 · 2
R24$153,000 · 1
Top collaborators
- Umut A. Gurkan1 shared
- Jeffrey M Jacobson1 shared
- Jonathan Karn1 shared
- Martin Sapp1 shared
- Katarzyna Zwolinska1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Scott Frederick Sieg$6,670,247
- Ge Jin$9,062,600
- Thomas S McCormick$4,069,015
- Kevin D Cooper$16,666,288
- Jonathan Karn$45,795,060
Others in their field
Top investigators on “Oral Mucous Membrane Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Keri, Hammel · The Emmes Company, Llc$11,064,901
- Kristina Abel · Univ Of North Carolina Chapel Hill$9,356,572
- Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh$9,021,964
- Donald L Sodora · Seattle Children'S Hospital$8,675,283
Research focus
Oral Mucous Membrane StructureEpithelial CellsOralOral CavityMicrobialInfectionBeta-DefensinsDefensinsAntimicrobialFusobacterium NucleatumReportingProteomicsCellsResponseImmuneSiteEpitheliumImmune ResponseImmune SystemBaseMucous MembraneClinical ResearchGene ExpressionInvestigation
Grant awards (53)
Epigenetics of dysfunctional oral epithelium in people living with HIV and risk for HPV infection$195,375
R21 · FY2024 · DE · contact PI
Epigenetics of dysfunctional oral epithelium in people living with HIV and risk for HPV infection$250,875
R21 · FY2023 · DE · contact PI
Innate and adaptive defenses against SARS-COV-2 in the oral cavity during acute unvaccinated and breakthrough infections$483,000
R56 · FY2022 · DE · contact PI
Microfluidic intact cell platform: A novel tool for oral cancer detection$413,972
R21 · FY2020 · CA · contact PI
HBD-3: A novel factor orchestrating microbial persistence in suspicious oral lesions$193,135
R21 · FY2020 · DE · contact PI
HBD-3: A novel factor orchestrating microbial persistence in suspicious oral lesions$259,606
R21 · FY2019 · DE · contact PI
Fusobacterial Associated Beta Defensin Inducer$475,109
R56 · FY2016 · DE · contact PI
Fusobacterial associated beta defensin inducer$386,242
R01 · FY2015 · DE · contact PI
Fusobacterial associated beta defensin inducer$468,285
R01 · FY2014 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$1,736,804
P01 · FY2013 · DE · contact PI
Fusobacterial associated beta defensin inducer$419,274
R01 · FY2013 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$393,472
P01 · FY2013 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$284,592
P01 · FY2013 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$1,579,999
P01 · FY2012 · DE · contact PI
Fusobacterial associated beta defensin inducer$451,348
R01 · FY2012 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$309,000
P01 · FY2012 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$309,000
P01 · FY2012 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$306,180
P01 · FY2012 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$142,893
P01 · FY2012 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$1,627,014
P01 · FY2011 · DE · contact PI
Fusobacterial associated beta defensin inducer$470,360
R01 · FY2011 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$316,628
P01 · FY2011 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$148,820
P01 · FY2011 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$1,665,551
P01 · FY2010 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$332,898
P01 · FY2010 · DE · contact PI
Ontogeny Of Oral Epithelial Antimicrobial Peptides$321,454
R01 · FY2010 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$155,398
P01 · FY2010 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$2,091,583
P01 · FY2009 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$337,550
P01 · FY2009 · DE · contact PI
Ontogeny Of Oral Epithelial Antimicrobial Peptides$324,702
R01 · FY2009 · DE · contact PI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations$157,000
P01 · FY2009 · DE · contact PI
Epithelial Immunity and Oral Complications in HIV$527,520
P01 · FY2008 · DE · contact PI
HBD-3-CXCR4: Molecular Mechanisms in Innate Immunity$527,520
P01 · FY2008 · DE · contact PI
B-defensin protection of human oral epithelial cells$344,096
R01 · FY2008 · DE · contact PI
Ontogeny Of Oral Epithelial Antimicrobial Peptides$324,702
R01 · FY2008 · DE · contact PI
B-defensin protection of human oral epithelial cells$347,923
R01 · FY2007 · DE · contact PI
Ontogeny Of Oral Epithelial Antimicrobial Peptides$314,415
R01 · FY2007 · DE · contact PI
Defense of oral epithelial cells from candida by hBDs$256,365
R01 · FY2007 · DE · contact PI
Oral Mucosal Beta Defensins and HIV$373,511
R01 · FY2006 · DE · contact PI
B-defensin protection of human oral epithelial cells$352,248
R01 · FY2006 · DE · contact PI
Defense of oral epithelial cells from candida by hBDs$264,022
R01 · FY2006 · DE · contact PI
Oral Mucosal Beta Defensins and HIV$382,500
R01 · FY2005 · DE
B-defensin protection of human oral epithelial cells$360,725
R01 · FY2005 · DE
Defense of oral epithelial cells from candida by hBDs$270,375
R01 · FY2005 · DE
Oral Mucosal Beta Defensins and HIV$382,500
R01 · FY2004 · DE
Oral Mucosal Beta Defensins and HIV$363,950
R01 · FY2003 · DE
CWRU School of Dentistry Research Planning Grant$153,000
R24 · FY2003 · DE
GINGIVAL EPITHELIAL CELL ANTIMICROBIAL PEPTIDES$233,352
R01 · FY2002 · DE
C.ALBICANS REGULATION BETA-DEFENSINS IN ORAL EPITHELIA$227,588
R01 · FY2002 · DE
C.ALBICANS REGULATION BETA-DEFENSINS IN ORAL EPITHELIA$227,588
R01 · FY2001 · DE
GINGIVAL EPITHELIAL CELL ANTIMICROBIAL PEPTIDES$226,554
R01 · FY2001 · DE
C ALBICANS REGULATION BETA-DEFENSINS IN ORAL EPITHELIA$246,495
R01 · FY2000 · DE
GINGIVAL EPITHELIAL CELL ANTIMICROBIAL PEPTIDES$219,958
R01 · FY2000 · DE